Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anaptysbio, Altamira, Anavex, EIP, H. Lundbeck, Mirati, Ondine, Otsuka, Qilu, SK, Theratechnologies, Urogen, Vanda, Vaxxinity, Ventyx.